Geron Stock Price Prediction

GERN Stock  USD 4.17  0.11  2.71%   
As of today, the RSI of Geron's share price is approaching 31. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Geron, making its price go up or down.

Oversold Vs Overbought

31

 
Oversold
 
Overbought
The successful prediction of Geron's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Geron, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Geron's stock price prediction:
EPS Estimate Next Quarter
(0.06)
EPS Estimate Current Year
(0.28)
EPS Estimate Next Year
(0.05)
Wall Street Target Price
7.45
EPS Estimate Current Quarter
(0.08)
Using Geron hype-based prediction, you can estimate the value of Geron from the perspective of Geron response to recently generated media hype and the effects of current headlines on its competitors.

Geron Hype to Price Pattern

Investor biases related to Geron's public news can be used to forecast risks associated with an investment in Geron. The trend in average sentiment can be used to explain how an investor holding Geron can time the market purely based on public headlines and social activities around Geron. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Geron's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Geron.
The fear of missing out, i.e., FOMO, can cause potential investors in Geron to buy its stock at a price that has no basis in reality. In that case, they are not buying Geron because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Geron after-hype prediction price

    
  USD 4.17  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Geron Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
Intrinsic
Valuation
LowRealHigh
0.643.526.40
Details
Naive
Forecast
LowNextHigh
1.404.287.17
Details
10 Analysts
Consensus
LowTargetHigh
4.404.835.36
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.08-0.07-0.07
Details

Geron After-Hype Price Prediction Density Analysis

As far as predicting the price of Geron at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Geron or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Geron, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Geron Estimiated After-Hype Price Volatility

In the context of predicting Geron's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Geron's historical news coverage. Geron's after-hype downside and upside margins for the prediction period are 1.29 and 7.05, respectively. We have considered Geron's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
4.17
4.17
After-hype Price
7.05
Upside
Geron is relatively risky at this time. Analysis and calculation of next after-hype price of Geron is based on 3 months time horizon.

Geron Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Geron is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Geron backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Geron, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.05 
2.76
 0.00  
  0.02 
10 Events / Month
13 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
4.17
4.17
0.00 
6,900  
Notes

Geron Hype Timeline

Geron is currently traded for 4.17. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Geron is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at -0.05%. %. The volatility of related hype on Geron is about 734.78%, with the expected price after the next announcement by competition of 4.19. About 85.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.32. Geron had not issued any dividends in recent years. The entity had 1058:1000 split on the 22nd of July 2014. Given the investment horizon of 90 days the next projected press release will be in about 10 days.
Check out Geron Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

Geron Related Hype Analysis

Having access to credible news sources related to Geron's direct competition is more important than ever and may enhance your ability to predict Geron's future price movements. Getting to know how Geron's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Geron may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
VKTXViking Therapeutics(6.17)10 per month 0.00 (0.04) 6.24 (8.05) 34.61 
TGTXTG Therapeutics 1.37 7 per month 3.03  0.14  7.62 (4.62) 24.51 
XFORX4 Pharmaceuticals 0.02 8 per month 0.00 (0.04) 8.82 (10.61) 62.35 
PDSBPDS Biotechnology Corp 0.10 10 per month 0.00 (0.12) 7.67 (6.76) 31.83 
MDGLMadrigal Pharmaceuticals 15.47 8 per month 2.13  0.08  5.17 (3.96) 30.27 
ZURAZura Bio Limited(0.21)9 per month 0.00 (0.11) 7.95 (7.94) 26.70 
ENVBEnveric Biosciences 0.08 6 per month 0.00 (0.15) 6.25 (7.50) 28.33 
EFTREffector Therapeutics(0.06)4 per month 0.00 (0.31) 8.70 (27.78) 88.91 
IMMXImmix Biopharma(0.04)4 per month 4.55 (0.02) 9.38 (8.22) 32.68 
ELEVElevation Oncology(0.02)9 per month 0.00 (0.08) 5.77 (8.22) 22.21 
SRPTSarepta Therapeutics(4.00)10 per month 1.98 (0.05) 3.75 (3.10) 9.65 
HEPAHepion Pharmaceuticals(0.02)4 per month 0.00 (0.06) 8.06 (8.11) 33.54 
PTCTPTC Therapeutics(0.65)9 per month 2.39  0.09  6.61 (4.33) 23.95 
CWBRCohBar Inc 0.07 3 per month 5.34  0.08  5.73 (5.59) 250.97 
OCEAOcean Biomedical 0.02 3 per month 0.00 (0.08) 7.46 (6.06) 28.33 
AVROAVROBIO 0.05 5 per month 1.89  0.01  4.11 (3.17) 14.20 

Geron Additional Predictive Modules

Most predictive techniques to examine Geron price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Geron using various technical indicators. When you analyze Geron charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Geron Predictive Indicators

The successful prediction of Geron stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Geron, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Geron based on analysis of Geron hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Geron's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Geron's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding461.951.9K2.5K2.7K
PTB Ratio3.1611.524.862.86

Story Coverage note for Geron

The number of cover stories for Geron depends on current market conditions and Geron's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Geron is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Geron's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Geron Short Properties

Geron's future price predictability will typically decrease when Geron's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Geron often depends not only on the future outlook of the potential Geron's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Geron's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding570.6 M
Cash And Short Term Investments333.7 M
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:
Check out Geron Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.32)
Revenue Per Share
0.047
Quarterly Revenue Growth
171.384
Return On Assets
(0.30)
Return On Equity
(0.69)
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.